ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases.

Cell Death Dis · 2025 · PMC12663164 · PMID 41315195

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The adjusted odds ratio (OR) of long-term BZRD use for liver cancer was highly significant (odds ratio = 1.81, 95% confidence interval 1.18–2.80) compared to controls, and this effect remained significant after applying propensity score calibration to eliminate confounding factors [ 41 , 42 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.